|
|
|
About Samyang Genex > About Our Plant> Plant > Daejeon Plant
|
|
|
|
|
|
|
|
|
To commercialize and begin mass production of Genexol (Paclitaxel), an anti-cancer drug,
Samyang Genex successfully developed plant tissue culture technology for the first time
in the world. With this achievement, Samyang Genex established the Taejon plant in Aug.1997.
The Taejon plant serves as a pharmaceutical production base with the most advanced production
facilities which meet the strictly standards required by the KGMP and cGMP. The plant also won
a DMF number for the production and sale of Genexol from the FDA in the U.S.
|
|
|
 Address : 1688-3 Sinil-dong, Daedeok-gu, Daejeon, Korea |
 Tel : +82-42-930-9304 |
| Fax : +82-42-934-1403 |
|
|
|
|
|
| Brief History |
|
1994-1998 Research and development
Aug. 1996 Construction of the plant initiated.
Aug. 1997 Production begins.
June 1998 Won its manufacturing license
Feb. 1999 Won the ISO9002
Aug. 1999 Granted a DMF number by FDA
|
|
 |
|
|
|
|
|
|
|
|
|
|
